SCHEMBL125319

SCHEMBL125319

CSc1cccc(N=C=O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.43
TRPA1 O75762 1/20 0.43
MAPK1 P28482 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
MAPT P10636 3/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
GABRA1 P14867 1/20 0.37
GABRB2 P47870 1/20 0.37
SIGMAR1 Q99720 2/20 0.37
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TSHR P16473 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29638353 1.00 CYP3A4 (0.43) CYP3A4TRPA1MAPK1TDP1MEN1
SCHEMBL8937136 0.84 MAPK1 (0.44) CYP3A4TRPA1MAPK1TDP1POLB
SCHEMBL9315146 0.84 MAPK1 (0.44) CYP3A4TRPA1MAPK1TDP1MAPT
SCHEMBL31134964 0.84 MAPK1 (0.44) CYP3A4TRPA1MAPK1TDP1POLB
SCHEMBL1457560 0.81 MIF (0.48) CYP3A4MAPK1TDP1MEN1KMT2A
SCHEMBL28080748 0.81 MAPK1 (0.41) CYP3A4TRPA1MAPK1TDP1GABRA1
SCHEMBL2651634 0.80 GABRA1 (0.42) CYP3A4TRPA1MAPK1TDP1GABRA1
SCHEMBL7529742 0.80 CYP4F2 (0.42) TDP1KMT2AMAPTTP53POLB
SCHEMBL11718768 0.79 CYP3A4 (0.46) CYP3A4TRPA1MAPK1TDP1MEN1
SCHEMBL28087260 0.79 MAPK1 (0.40) CYP3A4TRPA1MAPK1TDP1GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 558 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12509419-B2 Process for the distillation of isocyanates COVESTRO DEUTSCHLAND AG (DE) 2025-12-30 US claimed
US-20220380303-A1 PROCESS FOR THE DISTILLATION OF ISOCYANATES COVESTRO DEUTSCHLAND AG (DE) 2022-12-01 US claimed
EP-4038049-A1 PROCESS FOR THE DISTILLATION OF ISOCYANATES Covestro Intellectual Property GmbH & Co. KG (DE) 2022-08-10 EP claimed
CN-114423736-A Method for distilling isocyanates 科思创知识产权两合公司 2022-04-29 CN claimed
WO-2021063760-A1 PROCESS FOR THE DISTILLATION OF ISOCYANATES COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2021-04-08 WO claimed
EP-3798208-A1 METHOD FOR DISTILLATION OF ISOCYANATES Covestro Deutschland AG (DE) 2021-03-31 EP claimed
EP-1754705-A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders Genentech, Inc. (US) 2007-02-21 EP claimed
EP-1377589-B1 OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2005-09-07 EP claimed
US-12509419-B2 Process for the distillation of isocyanates COVESTRO DEUTSCHLAND AG (DE) 2025-12-30 US disclosed
US-12406696-B2 Photopolymer compositions for thermostable photopolymers in the visible spectral range COVESTRO DEUTSCHLAND AG (DE) 2025-09-02 US disclosed
US-20250182787-A1 Photopolymer Compositions for Thermostable Photopolymers in the Visible Spectral Range COVESTRO DEUTSCHLAND AG (DE) 2025-06-05 US disclosed
US-20250171648-A1 Thermostable Photopolymers in the Visible Spectral Range and Photopolymer Compositions Containing Same COVESTRO DEUTSCHLAND AG (DE) 2025-05-29 US disclosed
US-20250155845-A1 Triarylalkyl Borate Salts as Coinitiators in NIR Photopolymer Compositions COVESTRO DEUTSCHLAND AG (DE) 2025-05-15 US disclosed
CN-114423736-B Method for distilling isocyanates 科思创德国股份有限公司 2025-02-18 CN disclosed
US-4663341-A Insecticidal n-aryl-3-aryl-4,5-dihydro-1h-pyrazole-1-carboxamides ROHM AND HAAS COMPANY (US) 1987-05-05 US disclosed
EP-0153127-A2 N-aryl-3-aryl-4,5-dihydro-1H-pyrazole-1-carboxamides, processes for their production, insecticidal compositions containing them and methods for combatting insects ROHM AND HAAS COMPANY (US) 1985-08-28 EP disclosed
US-4514210-A Herbicidally active methyl-substituted tetrahydro-2-pyrimidinone derivatives NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1985-04-30 US disclosed
EP-0086411-A2 Methyl-substituted tetrahydro-2-pyrimidinone derivatives, process for their preparation and their use as herbicides, as well as intermediates for their preparation NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1983-08-24 EP disclosed
US-4046909-A Pyrrolidylidene, piperidylidene and hexahydroazepinylidene ureas as CNS depressants MCNEIL LABORATORIES, INCORPORATED (US) 1977-09-06 US disclosed
US-3998958-A Pyrrolidylidene, piperidylidene and hexahydroazepinylidene ureas as CNS depressants MCNEIL LABORATORIES, INCORPORATED (US) 1976-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12509419-B2 Process for the distillation of isocyanates ACMSD, MRPL9, CA9 CYP3A4 2868/4885TRPA1 2214/4885MAPK1 3741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.